摘要
目的:基于T细胞应答的免疫治疗是一种很有前途的肿瘤治疗方法.本研究旨在重新设计基于人工表位的免疫原,dna疫苗候选。评价ST黑色素瘤对体外产生的T细胞的细胞毒性作用. 方法:采用原计算方法预测T细胞表位,设计多表位黑色素瘤抗原。将编码靶抗原的人工基因克隆到dna va中。CCIN质粒载体转染DNA疫苗的HEK-293 T细胞在转录水平和翻译水平上均证实了靶基因的表达。树突状细胞HLA-A*02:01供者M粘附外周血单个核细胞。自体抗原提呈树突状细胞共培养诱导效应淋巴细胞对MEL的杀伤活性用乳酸脱氢酶释放法检测瘤Mel is细胞。用细胞内细胞因子染色和流式细胞术检测颗粒酶B产生CD8 T细胞的比例。 结果:构建了两种DNA疫苗pmel-tci和pmel-A 0201-编码6种免疫显性黑色素瘤抗原T细胞表位的多肽(NY-ESO-1,MART 1,MAGE-A1,MAG)。电子-A11,法师-A3,和法师-C1)。转染DNA疫苗构建的树突状细胞既能刺激自体淋巴细胞介导的肿瘤细胞毒性,也能刺激CD介导的颗粒酶B的产生。8个T细胞,PMEL-A 0201是最有效的。 结论:该方法可作为肿瘤免疫治疗疫苗设计的通用平台。
关键词: 黑色素瘤,抗肿瘤DNA疫苗,T细胞表位,人工多表位抗原,细胞毒性反应,MAGE。
Current Gene Therapy
Title:Design of Artificial Immunogens Containing Melanoma-associated T-cell Epitopes
Volume: 18 Issue: 6
关键词: 黑色素瘤,抗肿瘤DNA疫苗,T细胞表位,人工多表位抗原,细胞毒性反应,MAGE。
摘要: Objective: Immunotherapy based on induction of T-cell responses is a promising approach to cancer treatment. The study aims to design artificial epitope-based immunogens, DNA vaccine candidates against melanoma and evaluate their ability to stimulate tumor cytotoxicity of ex vivo generated T-cells.
Methods: The original computational methods were used for predicting T-cell epitopes and designing polyepitope melanoma antigens. Artificial genes encoding the target antigens were cloned into DNA vaccine plasmid vector. Target gene expression was confirmed both at transcriptional and translational level in HEK-293T cells transfected with DNA-vaccine constructs. Dendritic cells were generated from adherent peripheral blood mononuclear cells of HLA-A*02:01+ donors. Cytotoxic activity of effector lymphocytes stimulated in co-culture with autologous antigen-presenting dendritic cells towards melanoma Mel Is cells was assessed with lactate dehydrogenase release assay. The proportion of granzyme B producing CD8+ T-cells was estimated using intracellular cytokine staining and flow cytometry.
Results: Two DNA vaccine constructions were created - pMEL-TCI and pMEL-A0201 - encoding polypeptides containing T-cell epitopes of six immunodominant melanoma antigens (NY-ESO-1, MART1, MAGE-A1, MAGE-A11, MAGE-A3, and MAGE-C1). Dendritic cells transfected with DNA vaccine constructs were found to stimulate both tumor cytotoxicity mediated by autologous lymphocytes and granzyme B production by CD8+ T-cells, and pMEL-A0201 was found to be the most efficient.
Conclusion: The described approach may become a common platform for designing immunotherapeutic vaccines against oncological diseases.
Export Options
About this article
Cite this article as:
Design of Artificial Immunogens Containing Melanoma-associated T-cell Epitopes, Current Gene Therapy 2018; 18 (6) . https://dx.doi.org/10.2174/1566523218666181113112829
DOI https://dx.doi.org/10.2174/1566523218666181113112829 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
<i>Momordica balsamina L</i>.: An Appraisal on Morphology, Ecological Diversity,
Phytochemistry, Pharmacological and Biotechnological Applications
Current Traditional Medicine Ignored Avenues in Alpha-Synuclein Associated Proteopathy
CNS & Neurological Disorders - Drug Targets Asymmetric Vinylogous Mukaiyama Aldol Reactions Using Vinylketene N,O-Acetals in Total Syntheses of Natural Products
Mini-Reviews in Organic Chemistry Targeting PDK1 in Cancer
Current Medicinal Chemistry Cathepsin L Induces Proangiogenic Changes in Human Omental Microvascular Endothelial Cells via Activation of the ERK1/2 Pathway
Current Cancer Drug Targets Gene Therapy: Optimising DNA Delivery to the Nucleus
Current Drug Targets Reducing the Burden of Cervical Cancer in the Developing World
Current Women`s Health Reviews Upregulation of Focal Adhesion Kinase by 14-3-3ε via NFκB Activation in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Androgen Receptor in Human Health: A Potential Therapeutic Target
Current Drug Targets A Review on the Synthesis and Anti-cancer Activity of 2-substituted Quinolines
Anti-Cancer Agents in Medicinal Chemistry Cellular Functions of RNA-Binding Motif Protein 3 (RBM3): Clues in Hypothermia, Cancer Biology and Apoptosis
Protein & Peptide Letters Role of Rap2 and its Downstream Effectors in Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry Oxidative Stress in HIV Patients Receiving Antiretroviral Therapy
Current HIV Research Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update
Current Medicinal Chemistry Anti-infective Agents Produced by the Hyphomycetes Genera Trichoderma and Gliocladium
Current Medicinal Chemistry - Anti-Infective Agents microRNA, Cancer and Cancer Chemoprevention
Current Molecular Pharmacology Green Synthesis of Silver Nanoparticles Using Citrus Reticulata Juice and Evaluation of their Antibacterial Activity and Cytotoxicity Against Melanoma-B16/F10 Cells
Current Nanoscience Oleuropein Mediated Targeting of Signaling Network in Cancer
Current Topics in Medicinal Chemistry Immunotherapy for Non-Small Cell Lung Cancer - Finally a Hint of Hope
Reviews on Recent Clinical Trials The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor
Current Clinical Pharmacology